First Bank & Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-56
Closed -$5K 533
2022
Q1
$5K Hold
56
﹤0.01% 391
2021
Q4
$5K Hold
56
﹤0.01% 388
2021
Q3
$5K Hold
56
﹤0.01% 375
2021
Q2
$5K Hold
56
﹤0.01% 368
2021
Q1
$5K Hold
56
﹤0.01% 369
2020
Q4
$5K Sell
56
-37
-40% -$3.23K ﹤0.01% 353
2020
Q3
$8K Hold
93
0.01% 321
2020
Q2
$8K Sell
93
-124
-57% -$10.7K 0.01% 311
2020
Q1
$18K Sell
217
-387
-64% -$34.5K 0.02% 290
2019
Q4
$57K Sell
604
-192
-24% -$17.2K 0.04% 235
2019
Q3
$69K Sell
796
-270
-25% -$24.2K 0.05% 199
2019
Q2
$97K Buy
1,066
+520
+95% +$44K 0.08% 173
2019
Q1
$47K Sell
546
-21
-4% -$1.69K 0.04% 210
2018
Q4
$44K Sell
567
-30
-5% -$2.33K 0.04% 207
2018
Q3
$44K Sell
597
-80
-12% -$5.91K 0.03% 212
2018
Q2
$46K Sell
677
-313
-32% -$21.6K 0.04% 205
2018
Q1
$71K Sell
990
-1,003
-50% -$76.4K 0.06% 185
2017
Q4
$150K Sell
1,993
-3,227
-62% -$243K 0.12% 156
2017
Q3
$402K Sell
5,220
-2,565
-33% -$194K 0.33% 84
2017
Q2
$582K Sell
7,785
-8,599
-52% -$609K 0.49% 57
2017
Q1
$1.09M Buy
16,384
+3,779
+30% +$252K 0.94% 28
2016
Q4
$822K Buy
+12,605
New +$818K 0.75% 32

Other funds holding NVS

First Bank & Trust's NVS Position: Q2 2022 in Review

First Bank & Trust sold out of Novartis (NVS) in Q2 2022, closing a stake of 56 shares — an estimated $5K sold.

First Bank & Trust first reported a position in NVS in Q4 2016 and held it in 22 quarters. The position peaked at $1.09M in Q1 2017. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

  • First Bank & Trust reported no remaining Novartis position as of Q2 2022 after selling out during the quarter.
  • First Bank & Trust sold 56 Novartis shares in Q2 2022, an estimated $5K.
  • First Bank & Trust first reported a position in Novartis in Q4 2016 and held it in 22 quarters.
  • First Bank & Trust's Novartis position peaked at $1.09M in Q1 2017.
  • 1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on First Bank & Trust's 13F filing for Q2 2022, filed 22 Jul 2022.